65 -- Pentostam

In accordance with FAR subpart 13.106-1(b) the Centers for Disease Control and Prevention (CDC) intends to issue a sole source purchase order to GlaxoSmithKline, Brentford, Middlesex, UNITED KINGDOM, in the amount of $31,764.00 for the purchase of Sodium Stibogluconate (Pentostam). CDC believes that GlaxoSmithKline is the only organization that can meet the requirements of the order because there is no other source in the U.S. for this drug. This drug is distributed under U. S. Food and Drug Administration (FDA) Investigational New Drug (IND) Application Number 84831. Interested parties who feel that they possess the capabilities to provide this service described above should submit a capabilities statement demonstrating their abilities to provide the service. The information received in response to this notice will be considered solely for the purpose of determining whether or not to conduct a competitive procurement. Please send your documentation to Ronnie Francis at the office identified above, by fax (770) 488-2688 or by e-mail to [email protected]. Documentation should be received within fifteen (15) days after the date of publication of this synopsis to be considered by CDC. A determination by the CDC not to compete this proposed contract based upon responses to this notice is solely within discretion of the government.